We are live on ! Find out more
OC

Oppenheimer & Co Portfolio holdings

AUM $8.21B
1-Year Est. Return 28.81%
This Fund
S&P 500
This Quarter Est. Return
+4.01%
1 Year Est. Return
+28.81%
3 Year Est. Return
+92.54%
5 Year Est. Return
+114.67%
10 Year Est. Return
+429.8%
AUM
$6.7B
AUM Growth
+$144M
Cap. Flow
+$80.4M
Cap. Flow %
1.2%
Top 10 Hldgs %
21%
Holding
1,675
New
169
Increased
710
Reduced
579
Closed
127

Sector Composition

Rank Sector Weight
1 Technology 21.11%
2 Financials 10.66%
3 Industrials 8.29%
4 Consumer Discretionary 7.5%
5 Healthcare 7.13%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
A icon
651
Agilent Technologies
A
$39.2B
$1.45M 0.02%
10,771
+194
+2% +$26.6K
MRCY icon
652
Mercury Systems
MRCY
$5.76B
$1.45M 0.02%
34,450
-5,078
-13% -$194K
BNDX icon
653
Vanguard Total International Bond ETF
BNDX
$82.1B
$1.44M 0.02%
29,408
+878
+3% +$43.9K
LEVI icon
654
Levi Strauss
LEVI
$9.45B
$1.44M 0.02%
83,311
-4,450
-5% -$78.8K
GEHC icon
655
GE HealthCare
GEHC
$31.6B
$1.44M 0.02%
18,407
-3,833
-17% -$326K
DINO icon
656
HF Sinclair
DINO
$16.7B
$1.44M 0.02%
41,049
-3,416
-8% -$140K
CAPR icon
657
Capricor Therapeutics
CAPR
$243M
$1.44M 0.02%
104,231
+35,823
+52% +$628K
VTWO icon
658
Vanguard Russell 2000 ETF
VTWO
$17.4B
$1.43M 0.02%
16,051
+3,683
+30% +$340K
LDP icon
659
Cohen & Steers Duration Preferred & Income Fund
LDP
$600M
$1.43M 0.02%
70,972
+6,682
+10% +$141K
ABEV icon
660
Ambev
ABEV
$48.2B
$1.43M 0.02%
774,359
-25,193
-3% -$55.7K
IJT icon
661
iShares S&P Small-Cap 600 Growth ETF
IJT
$8.27B
$1.43M 0.02%
10,542
+654
+7% +$92.5K
HRL icon
662
Hormel Foods
HRL
$14B
$1.42M 0.02%
45,297
-82
-0.2% -$2.57K
UCTT
663
Ultra Clean Holdings
UCTT
$3.73B
$1.42M 0.02%
+39,379
New +$1.46M
NNN icon
664
NNN REIT
NNN
$9.16B
$1.41M 0.02%
34,536
-890
-3% -$39.4K
FEX icon
665
First Trust Large Cap Core AlphaDEX Fund
FEX
$1.57B
$1.4M 0.02%
13,389
+6
+0% +$643
SHLD icon
666
Global X Defense Tech ETF
SHLD
$7B
$1.4M 0.02%
+37,300
New +$1.44M
WST icon
667
West Pharmaceutical
WST
$23.9B
$1.39M 0.02%
4,247
BWA icon
668
BorgWarner
BWA
$13.2B
$1.39M 0.02%
43,600
-3,485
-7% -$119K
STX icon
669
Seagate
STX
$193B
$1.39M 0.02%
16,055
-5,035
-24% -$507K
CEFS icon
670
Saba Closed-End Funds ETF
CEFS
$425M
$1.38M 0.02%
64,656
+2,595
+4% +$57.4K
URI icon
671
United Rentals
URI
$66.5B
$1.38M 0.02%
1,963
+46
+2% +$37.4K
TRI icon
672
Thomson Reuters
TRI
$43.1B
$1.38M 0.02%
8,469
+7
+0.1% +$1.18K
SYF icon
673
Synchrony
SYF
$25.1B
$1.38M 0.02%
21,203
+3,824
+22% +$234K
BST icon
674
BlackRock Science and Technology Trust
BST
$1.59B
$1.37M 0.02%
37,593
-2,119
-5% -$77.8K
KTOS icon
675
Kratos Defense & Security Solutions
KTOS
$8.66B
$1.37M 0.02%
51,913
-38,840
-43% -$995K

Similar funds

Oppenheimer & Co's Q4 2024 Portfolio in Review

As of Q4 2024, Oppenheimer & Co held 1,675 positions worth $6.7B, up 2.2% from $6.56B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Oppenheimer & Co's Q4 2024 filing shows 169 new, 710 increased, 579 reduced and 127 closed positions. Its largest new stake was FT Vest US Equity Deep Buffer ETF November: 493,441 shares worth $21.2M. The largest sale was FT Vest US Equity Deep Buffer ETF March, an estimated $21.8M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Financials and Industrials.

  • Oppenheimer & Co's largest Q4 2024 buy was FT Vest US Equity Deep Buffer ETF November: 493,441 shares worth $21.2M.
  • Oppenheimer & Co added most to iShares Russell Mid-Cap Growth ETF in Q4 2024, an estimated $12.8M increase.
  • Oppenheimer & Co's biggest Q4 2024 reduction was FT Vest US Equity Deep Buffer ETF March, cutting an estimated $21.8M.
  • Oppenheimer & Co fully exited Innovative Industrial Properties in Q4 2024, selling an estimated $6.32M.
  • Oppenheimer & Co's ten largest holdings make up 21% of its $6.7B portfolio in Q4 2024.
  • Oppenheimer & Co opened 169 new positions and closed 127 in Q4 2024.
  • Oppenheimer & Co's portfolio value rose 2.2% quarter-over-quarter to $6.7B.

Based on Oppenheimer & Co's 13F filing for Q4 2024, filed 5 Feb 2025.